Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Reshape Lifesciences Inc (RSLS)

Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Reshape Lifesciences Inc 18 Technology Dr Suite 110 Irvine CA 92618 USA

www.reshapelifesciences.com P: 949-429-6680

Description:

ReShape Lifesciences Inc. provides weight-loss solutions. It offers an integrated portfolio of proven products and services which manage and treat obesity and metabolic disease. ReShape Lifesciences Inc., formerly known as Obalon Therapeutics, is based in SAN CLEMENTE, CA.

Key Statistics

Overview:

Market Capitalization, $K 2,208
Enterprise Value, $K -2,352
Shares Outstanding, K 13,135
Annual Sales, $ 8,680 K
Annual Net Income, $ -11,390 K
Last Quarter Sales, $ 1,980 K
Last Quarter Net Income, $ -1,700 K
EBIT, $ -15,390 K
EBITDA, $ -15,240 K
60-Month Beta 0.22
% of Insider Shareholders 0.10%
% of Institutional Shareholders 22.06%
Float, K 13,122
% Float 99.90%
Short Volume Ratio 0.77

Growth:

1-Year Return -93.04%
3-Year Return -99.96%
5-Year Return -99.97%
5-Year Revenue Growth -4.62%
5-Year Earnings Growth 99.94%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.02 on 11/08/23
Latest Earnings Date 05/20/24
Earnings Per Share ttm -3.66
EPS Growth vs. Prev Qtr 5.56%
EPS Growth vs. Prev Year 90.29%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-50 on 12/23/22

RSLS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -187.89%
Return-on-Assets % -97.55%
Profit Margin % -131.22%
Debt/Equity 0.00
Price/Sales 0.26
Price/Cash Flow N/A
Price/Book 0.33
Book Value/Share 0.51
Interest Coverage -379.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar